GE HealthCare Technologies Inc. GEHC | NASDAQ
Next Earnings: Jul 31, 2026
Company Overview:
3.6 Year GEHC Performance Metrics:
GEHC Dividend Payments, Yield & Share Price charts
Unlock All Reports & Research Dividend Stocks.
[lev_ptables no_sale]GEHC Dividend Safety: Payout & Dividend to Free Cash Flow Ratios.
GEHC Earnings, Revenue, Cash & Debt, Shares Outstaning:
Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:
Ratios, Profit Margins & Return on Capital:
GEHC Dividends Info:
GEHC Dividend History: Dates, Payments & Yield list
Below is a schedule of all GEHC dividend payments, ex-dates, share price on the day of the payment as well as TTM & forward yield
| Ex-Date | Payment Date | Amount | TTM Yield | Forward Yield | Price on Ex-Date |
|---|---|---|---|---|---|
| 07/24/2026 | 08/14/2026 | $0.035 | 0.23% | 0% | $0.00 |
| 04/02/2026 | 05/15/2026 | $0.035 | 0.2% | 0.23% | $60.76 |
| 01/09/2026 | 02/13/2026 | $0.035 | 0.16% | 0.17% | $80.34 |
| 10/24/2025 | 11/14/2025 | $0.035 | 0.18% | 0.19% | $73.15 |
| 07/25/2025 | 08/15/2025 | $0.035 | 0.17% | 0.19% | $73.40 |
| 04/25/2025 | 05/15/2025 | $0.035 | 0.19% | 0.19% | $72.91 |
| 01/14/2025 | 02/14/2025 | $0.035 | 0.15% | 0.15% | $92.21 |
| 10/18/2024 | 11/15/2024 | $0.030 | 0.13% | 0.15% | $81.76 |
| 07/19/2024 | 08/15/2024 | $0.030 | 0.15% | 0.14% | $85.30 |
| 04/18/2024 | 05/15/2024 | $0.030 | 0.14% | 0.15% | $81.91 |
| 04/15/2024 | 05/15/2024 | $0.030 | 0.14% | 0.15% | $81.91 |
| 01/12/2024 | 02/15/2024 | $0.030 | 0.16% | 0.14% | $85.63 |
| 10/19/2023 | 11/15/2023 | $0.030 | 0.14% | 0.17% | $71.52 |
| 07/20/2023 | 08/15/2023 | $0.030 | 0.07% | 0.17% | $70.54 |
| 05/22/2023 | 06/15/2023 | $0.030 | 0.04% | 0.15% | $79.10 |
Projected Future Returns & Dividends for GEHC
Based on past 3.6-year performance, here are GEHC growth metrics:
Share price CAGR of +3.38%
Dividend CAGR of +4.99%
Using GEHC CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:
| GEHC (DRIP) | GEHC - No DRIP | |
|---|---|---|
| Current Price | $67.63 | $67.63 |
| Start Shares | 147.86 | 147.86 |
| Start Value | $10,000 | $10,000 |
| After 10 years: | ||
| Final Share Count | 151.18 | 147.86 |
| Dividends Payment | $0.06 | $0.06 |
| Annual Dividends | $34 | $34 |
| Yield on cost | 0.34% | 0.34% |
| Share Price | $94.31 | $94.31 |
| Total Dividends | $263 | $260 |
| Final Value | $14,258 | $14,205 |
NOTE: Above numbers are our estimate based on GEHC's Dividend and Price CAGR over past 3.6 years.
These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.
We cannot guarantee that your actual returns will meet these estimates.
Get the best Dividend Stock Research Tools:
[lev_ptables no_sale]Company Info
GE HealthCare Technologies Inc. (GEHC) had its IPO on 2022-12-15, and is trader on NASDAQ stock exchange.
GE HealthCare Technologies Inc. is a global medical technology company that creates, manufactures, and markets a diverse range of medical devices, services, and integrated digital solutions. These offerings are designed to assist in the diagnosis, treatment, and ongoing monitoring of patients. The company boasts an extensive international presence, serving markets across the United States, Canada, Europe, the Middle East, Africa, China, Taiwan, Mongolia, and Hong Kong, among other regions. Its operations are structured across four primary business divisions: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging division specializes in advanced diagnostic imaging technologies, including systems for molecular imaging, Computed Tomography (CT) scans, Magnetic Resonance (MR) imaging, image-guided therapy, and X-ray, alongside specialized women's health products. The Ultrasound segment delivers a comprehensive suite of ultrasound solutions utilized for the screening, diagnosis, treatment, and monitoring of various diseases. These applications span radiology, primary care, women's health, cardiovascular diagnostics, point-of-care, and portable handheld devices, in addition to products supporting surgical visualization and guidance. The Patient Care Solutions segment is dedicated to providing essential medical devices, consumable products, services, and digital platforms. Its portfolio encompasses patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, and maternal-infant care products. The Pharmaceutical Diagnostics segment supplies specialized diagnostic agents to the radiology and nuclear medicine industries. These include contrast media pharmaceuticals, administered to patients prior to scans like CT, angiography, X-ray, and MR, to enhance the visibility of internal tissues and structures. It also offers molecular imaging agents, or radiopharmaceuticals – molecular tracers labeled with radioisotopes – injected into patients for advanced diagnostic imaging applications such as Single-Photon Emission Computed Tomography (SPECT), Positron Emission Tomography (PET), and specific ultrasound procedures. Established in 2022, GE HealthCare Technologies Inc. maintains its corporate headquarters in Chicago, Illinois.
GEHC website: https://www.gehealthcare.com
